Supriya Lifescience Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -
714.45 -34.60 (-4.62%)Updated : 23 Jan 2026
Fiscal Period2025202420232022
Period End DateMar 25Mar 24Mar 23Mar 22
Total Operating Expense 456.13413.16343.77325.71
Other Net -1.100.76-1.43-1.46
Total Adjustmentsto Net Income 0.01---
Diluted Weighted Average Shares 8.058.058.058.05
Gain( Loss)on Saleof Assets -0.010.00-0.11-
Depreciation/ Amortization 20.4415.8211.8210.12
Operating Income 240.36157.21117.17204.34
Net Income 187.96119.1189.86151.81
Income Availableto Com Excl Extra Ord 187.96119.1189.86151.81
Other Operating Expenses Total 3.452.032.292.79
Net Income Before Taxes 248.48165.69123.49207.24
Net Income After Taxes 187.96119.1189.86151.81
Income Availableto Com Incl Extra Ord 187.96119.1189.86151.81
Costof Revenue Total 248.47257.50206.98213.75
Gross Profit 448.01312.87253.96316.30
Interest Inc( Exp) Net- Non- Op Total 9.227.737.874.36
Unusual Expense( Income) 8.916.696.67-0.34
Diluted Net Income 187.96119.1189.86151.81
DPS- Common Stock Primary Issue 1.000.800.600.60
Provisionfor Income Taxes 60.5246.5833.6355.44
period Type ----
Net Income Before Extra Items 187.96119.1189.86151.81
Total Revenue 696.49570.37460.94530.05
period Length 12.0012.0012.0012.00
Revenue 696.49570.37460.94530.05
Selling/ General/ Admin Expenses Total 170.80130.03114.7797.72
Diluted Normalized EPS 24.1915.4011.7818.83
Research Development 4.051.091.241.66
Diluted EPS Excluding Extra Ord Items 23.3514.8011.1618.86
*All figures in crores except per share values
Recommended For You
Trending Stocks
189.20+4.85(2.63%)
276.50-6.90 (-2.43%)
4,024.00-56.20 (-1.38%)